OVER-THE-COUNTER DRUGS

Turn OTC Requirements into a Practical Product and Compliance Plan

OTC drugs are available in various dosage forms, including tablets, capsules, syrups, creams, ointments, lotions, gels, and shampoos. Each product must align its active ingredients, indications, dosage, warnings, labeling, manufacturing requirements, and registration details with the appropriate regulatory pathway. ProConXol helps companies evaluate these requirements, prepare for launch, and maintain ongoing regulatory compliance throughout the product lifecycle.

Discuss Your OTC Drug Product

A PRACTICAL STARTING POINT

Support for Monograph and Application-Based OTC Programs

We help determine whether the proposed product fits an applicable OTC monograph, requires a different formulation or claims strategy, or may need an approved application pathway. The work is tailored to the product, manufacturer, business role, and target market.

HOW WE CAN HELP

Support designed around the work in front of you.

01

Regulatory Strategy & Product Assessment

Review active ingredients, dosage form, route, indication, patient population, directions, warnings, and claims against the intended pathway. Identify gaps, options, and decisions before significant launch investment.

02

Quality Systems & cGMP Readiness

Develop, assess, and improve quality management systems for OTC drug manufacturers in compliance with FDA cGMP requirements (21 CFR Parts 210 and 211), including SOPs, validation, supplier controls, production and laboratory controls, deviations, CAPA, complaints, change control, and recordkeeping.

03

Drug Facts Labeling & Promotional Material Review

Develop or review Drug Facts labeling, principal display information, warnings, directions, inactive ingredients, packaging, websites, NDC number, and promotional materials for consistency with applicable requirements and the product’s lawful marketing basis.

04

Establishment Registration, Drug Listing & NDC/SPL Support

Support OTC drug manufacturers with establishment registrations, state licensing, NDC number assignments, product listings, SPL submissions, and renewal management to maintain compliance with FDA’s 21 CFR Part 207 and applicable state requirements.

05

OTC Monograph Order & OMUFA Support

Help teams understand the documentation, coordination, and operational implications of the current OTC monograph framework and OMUFA when relevant.

06

Post-Market Compliance & Recall Readiness

Support adverse-event and complaint processes, investigations, trend review, safety escalation, recall handling with regulatory agencies, field actions, and responses to agency questions.

07

Inspection & Audit Support

Prepare facilities and teams through gap assessments, mock inspections, document readiness, staff coaching, observation responses, remediation plans, and CAPA follow-through.

08

International Registration & Market Entry

Prepare and manage global registration dossiers for OTC drugs, including submissions and compliance coordination with regulatory agencies in markets such as the U.S., EU, Canada, and other international jurisdictions.

09

Import & Export Support

Support compliant global trade in OTC drug products through import/export procedure guidance, international trade compliance, documentation review, detention resolution, and preparation of export certificates (FSC, CoE, CFG) and regulatory documentation.

010

Virtual Regulatory Staffing Support

Access experienced regulatory professionals through flexible remote staffing solutions tailored to your project needs and business requirements. We provide contract-based hourly, fixed-rate, part-time, and full-time regulatory personnel, significantly reducing the cost and commitment of traditional hiring.

WHY IT MATTERS

An NDC is an identifier—not an FDA approval.

Drug establishment registration, product listing, and inclusion in the NDC Directory do not mean FDA has approved the product or verified the submitted information. Public-facing copy and internal teams should use precise language about product status.

COMMON QUESTIONS

Clear answers before the work begins.

Does every OTC drug follow the same monograph?+

No. The applicable requirements depend on the active ingredient, dosage form, route, indication, population, directions, warnings, and other product details.

Can you help with NDC and SPL submissions?+

Yes. We can support labeler-code, establishment-registration, drug-listing, NDC data, and SPL activities based on the company’s role and responsibility.

Does an NDC number mean the product is approved?+

No. An NDC identifies a listed drug product. Registration and listing do not, by themselves, establish that FDA approved the product.

Can you review marketing claims?+

Yes. We can review labels and promotional content together to improve consistency with the product’s lawful marketing basis and reduce misleading or unsupported language.

LET’S MOVE FORWARD

Preparing an OTC Launch or Correcting an Existing Listing?

Share your formulation, proposed claims, draft label, manufacturing arrangement, and target launch date. We will help you identify the right workstream and the records needed to support it.

Talk With an OTC Drug Specialist